Vanguard Investments Australia, Ltd.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1550100
Victoria, C3
Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$6,115,502
New position
Shares Held
46,421
first reported quarter
Ownership
0.046%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vanguard Investments Australia, Ltd. holds $77,267,480 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
219,718 | $25,972,864 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
532,782 | $16,047,393 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
19,051 | $11,296,861 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
46,421 | $6,115,502 | |
| 5 | VTRS |
Viatris Inc
|
290,719 | $3,927,613 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
126,256 | $3,021,306 | |
| 7 | ALKS |
Alkermes plc.
|
38,147 | $1,348,877 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
16,736 | $1,269,425 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,115,502 | 46,421 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||